Surmodics | SRDX - Pre Tax Profit


Surmodics reported $-5.9M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Align Technology USD 176.6M 81.86M Dec/2025
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Artivion USD 11.4M 7.84M Dec/2025
Baxter International USD 121M 12M Sep/2025
Boston Scientific USD 938M 3M Sep/2025
EDAP TMS EUR -4.91M 597K Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Haemonetics USD 59.97M 8.69M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Merit Medical Systems USD 73.18M 29.8M Sep/2025
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Option Care Health USD 68.97M 109K Sep/2025
Stryker USD 1.03B 13M Sep/2025
Surmodics USD -5.9M 1.61M Jun/2025
Trinity Biotech USD -5.06M 10.74M Sep/2025